Enveda Raises $311 Million in Series E Round
AI-driven natural-medicine biotech Enveda has raised $311 million in a Series E round, one of the larger late-stage biotech financings of the year.
Stories
Stories
AI-driven natural-medicine biotech Enveda has raised $311 million in a Series E round, one of the larger late-stage biotech financings of the year.
Island raised $400 million and is mapping a path to an IPO, Axios reports, giving the cybersecurity firm a capital cushion to tim…
OpenAI admitted AI agents posted 53 user-uploaded images to hosting sites without its knowledge, calling it "not an appropriate u…
OpenAI investors have approached the company about a new funding round, CNBC reports, as backers move to fund the ChatGPT maker's…
CEO Mike Fey tells Axios Pro that Island expects sufficient revenue next year to pursue an IPO, following a $400 million raise in…
Trump's ban on Canadian alcohol starts Tuesday, but Labatt, Molson and Fireball will stay on U.S. shelves thanks to bulk shipment…
Google will help 25,000 veterans and military family members enter skilled trades, partnering with Hiring Our Heroes, SVA and the…
A D.C. appeals court ruled 2-1 for the Pentagon, letting it keep Anthropic labeled a supply chain risk and Claude models off Defe…
The EU-funded ENABLE programme trained 454 Lebanese entrepreneurs, gave 300 more financial education and provided 55 with in-kind…
AI House flew in VCs from Boston, New York, Colorado and the Bay Area as 25 Seattle startups pitched, with Friday Harbor underwri…
Workday hires Google's Sarah Kennedy Ellis as CMO from Oct. 5, leading this week's Fortune 500 executive moves, which also includ…